Compare ORA & BCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ORA | BCPC |
|---|---|---|
| Founded | 1965 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Major Chemicals |
| Sector | Utilities | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 5.3B |
| IPO Year | 2004 | 1995 |
| Metric | ORA | BCPC |
|---|---|---|
| Price | $91.68 | $168.06 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 3 |
| Target Price | $126.33 | ★ $209.25 |
| AVG Volume (30 Days) | ★ 765.5K | 178.5K |
| Earning Date | 11-04-2026 | 10-23-2026 |
| Dividend Yield | 0.54% | ★ 0.57% |
| EPS Growth | N/A | ★ 20.87 |
| EPS | 1.14 | ★ 2.63 |
| Revenue | $719,267,000.00 | ★ $799,023,000.00 |
| Revenue This Year | $19.21 | $9.11 |
| Revenue Next Year | N/A | $5.67 |
| P/E Ratio | $77.76 | ★ $63.87 |
| Revenue Growth | N/A | ★ 13.56 |
| 52 Week Low | $87.06 | $140.70 |
| 52 Week High | $146.39 | $183.90 |
| Indicator | ORA | BCPC |
|---|---|---|
| Relative Strength Index (RSI) | 44.35 | 49.96 |
| Support Level | $87.06 | $167.19 |
| Resistance Level | $98.77 | $169.75 |
| Average True Range (ATR) | 2.33 | 3.01 |
| MACD | 0.22 | 0.45 |
| Stochastic Oscillator | 42.82 | 71.53 |
Ormat Technologies Inc is engaged in the geothermal and recovered energy power business. It is engaged in three business segments: the Electricity Segment. where the company develops, builds, owns, and operates geothermal, solar PV, and recovered energy-based power plants in the United States and geothermal power plants in other countries and sells the electricity generated. Product Segment includes designing, manufacturing, and selling equipment for geothermal and recovered energy-based electricity generation and providing services relating to the engineering, procurement, and construction of geothermal & recovered energy-based power plants. Energy Storage Segment includes owning & operating grid-connected which provide capacity, energy, & ancillary services directly to the electric grid.
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.